Cayman Pharma s.r.o.
Global Leader in cGMP Prostaglandin APIs
Manufacturer of prostaglandin APIs: Bimatoprost, Latanoprost, Latanoprostene Bunod, Travoprost and Tafluprost for treatment of Glaucoma; Epoprostenol for management of pulmonary hypertension; Cloprostenol for livestock oestrus synchronization.
- Type
- Manufacturer
- Location
- Czechia
- Founded
- 2001
- Website
- https://www.caymanpharma.com/
- Categories
- Chemicals & Plastics
Listed in a source registry
Verified facts
- domain-registered (green), checked 2026-08-02 Domain registry record
- gmp-certified (green), checked 2026-08-21 ANVISA (Brazilian Health Regulatory Agency), public register of Good Manufacturing Practice certificates (CBPF)
- lei-active (green), checked 2026-08-23 GLEIF global LEI register (golden copy)
- registered-since (green), checked 2001-12-17 ARES (Czech business register)
- directors-on-file (green), checked 2026-08-24 ARES (Czech business register)
- leadership-on-record (green), checked 2013-06-26 ARES (Czech business register)
- facility-registered (green), checked 2026-08-16 European Industrial Emissions Portal (E-PRTR / IED), European Environment Agency
- export-registered (green), checked 2026-07-30 EU EORI validation (European Commission)
- vat-valid (green), checked 2026-08-01 VIES (European Commission)
- registry-active-global (green), checked 2026-07-08 ARES
- registered-manufacturer (green), checked 2026-07-08 ARES
Claimed certifications
- Good Manufacturing Practice
Import rules for these goods
- Chemical substances imported into the EU above 1 tonne/year must be REACH-registered. ECHA (REACH)